The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
6-benzo[b]thiophen-3-ylindolo[1,2-c]quinazoline ID: ALA1087503
PubChem CID: 45276789
Max Phase: Preclinical
Molecular Formula: C23H14N2S
Molecular Weight: 350.45
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: c1ccc2c(c1)cc1c3ccccc3nc(-c3csc4ccccc34)n21
Standard InChI: InChI=1S/C23H14N2S/c1-5-11-20-15(7-1)13-21-17-9-2-4-10-19(17)24-23(25(20)21)18-14-26-22-12-6-3-8-16(18)22/h1-14H
Standard InChI Key: SXVPTUAVVZGYIZ-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 31 0 0 0 0 0 0 0 0999 V2000
4.8098 -8.3146 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8855 -9.1380 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6351 -9.4825 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4798 -7.8378 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9931 -7.8477 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2297 -8.1785 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3096 -9.0073 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5432 -8.4670 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1206 -9.1826 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.5288 -9.9042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3595 -9.9116 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.3696 -8.4725 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7788 -9.1892 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6020 -9.1922 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0172 -8.4793 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6031 -7.7620 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7812 -7.7626 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1103 -10.6147 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8204 -11.9149 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
7.4370 -11.3659 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1085 -11.4969 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2884 -10.6949 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6846 -10.1400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9005 -10.3859 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7237 -11.1918 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3289 -11.7432 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
12 13 2 0
3 7 2 0
13 14 1 0
5 6 1 0
14 15 2 0
7 9 1 0
15 16 1 0
8 5 2 0
16 17 2 0
17 12 1 0
1 2 2 0
10 18 1 0
6 4 2 0
8 9 1 0
18 22 1 0
21 19 1 0
19 20 1 0
20 18 2 0
4 1 1 0
9 10 1 0
21 22 2 0
6 7 1 0
22 23 1 0
10 11 2 0
23 24 2 0
11 13 1 0
24 25 1 0
12 8 1 0
25 26 2 0
26 21 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 350.45Molecular Weight (Monoisotopic): 350.0878AlogP: 6.52#Rotatable Bonds: 1Polar Surface Area: 17.30Molecular Species: NEUTRALHBA: 3HBD: ┄#RO5 Violations: 1HBA (Lipinski): 2HBD (Lipinski): ┄#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 0.61CX LogP: 5.71CX LogD: 5.71Aromatic Rings: 6Heavy Atoms: 26QED Weighted: 0.33Np Likeness Score: -0.95
References 1. Rohini R, Muralidhar Reddy P, Shanker K, Hu A, Ravinder V.. (2010) Antimicrobial study of newly synthesized 6-substituted indolo[1,2-c]quinazolines., 45 (3): [PMID:20005020 ] [10.1016/j.ejmech.2009.11.038 ] 2. Van Horn KS, Burda WN, Fleeman R, Shaw LN, Manetsch R.. (2014) Antibacterial activity of a series of N2,N4-disubstituted quinazoline-2,4-diamines., 57 (7): [PMID:24625106 ] [10.1021/jm500039e ]